What is King Pharmaceuticals's asset turnover?

King Pharmaceuticals (KG) reported asset turnover of 0.1× in Q4 2025.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

King Pharmaceuticals KG Asset turnover

Asset turnover at other companies

Arch Capital GroupACGL

0.3×0.0×

Everest GroupEG

0.3×0.0×

SiriusPointSPNT

0.3×+0.1×

KKR & Co.KKR

0.1×0.0×

Skyward Specialty Insurance Group, Inc.SKWD

0.3×0.0×

Tiptree Inc.TIPT

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Calculated from King Pharmaceuticals’s reported figures.

total revenue/total assets=0.1×

Based on trailing twelve months.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's asset turnover?: King Pharmaceuticals (KG) reported asset turnover of 0.1× in Q4 2025.
What does asset turnover mean?: Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.